Search details
1.
Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome.
Cell
; 166(3): 766-778, 2016 Jul 28.
Article
in English
| MEDLINE | ID: mdl-27453469
2.
Taxane chemotherapy induces stromal injury that leads to breast cancer dormancy escape.
PLoS Biol
; 21(9): e3002275, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37699010
3.
Neoadjuvant Triplet Chemotherapy with Docetaxel, Cisplatin plus 5-Fluorouracil versus Docetaxel, Cisplatin plus S-1 for Advanced Esophageal Squamous cell Carcinoma: Propensity Score Matched Analysis.
Oncology
; 102(3): 228-238, 2024.
Article
in English
| MEDLINE | ID: mdl-37708864
4.
Long-term survival after neoadjuvant therapy for triple-negative breast cancer under different treatment regimens: a systematic review and network meta-analysis.
BMC Cancer
; 24(1): 440, 2024 Apr 09.
Article
in English
| MEDLINE | ID: mdl-38594636
5.
Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer.
FASEB J
; 37(9): e23145, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37584654
6.
Prevalence of germline BRCA1/2 pathogenic variants in Japanese patients treated with castration-resistant prostate cancer and efficacy of CRPC treatment in real-world clinical practice.
Jpn J Clin Oncol
; 54(4): 489-497, 2024 Apr 06.
Article
in English
| MEDLINE | ID: mdl-38157885
7.
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 559-563, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38538963
8.
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis.
Lancet Oncol
; 24(6): 611-623, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37269842
9.
Association of immune-related expression profile with sensitivity to chemotherapy in esophageal squamous cell carcinoma.
Cancer Sci
; 114(11): 4459-4474, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37715346
10.
Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration-resistant prostate cancer.
Prostate
; 83(10): 950-961, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37074030
11.
Conditional survival does not improve over time in metastatic castration-resistant prostate cancer patients undergoing docetaxel.
Prostate
; 83(13): 1238-1246, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37290911
12.
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer.
Prostate
; 83(3): 227-236, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36382533
13.
Real-World Treatment Trends Among Patients with Metastatic Castration-Sensitive Prostate Cancer: Results from an International Study.
Oncologist
; 28(9): 780-789, 2023 09 07.
Article
in English
| MEDLINE | ID: mdl-37014080
14.
Real-World Treatment Patterns Among Patients With Metastatic Castration-Resistant Prostate Cancer: Results From an International Study.
Oncologist
; 28(9): e737-e747, 2023 09 07.
Article
in English
| MEDLINE | ID: mdl-37014097
15.
Taxane-Based Chemotherapy Is Effective in Metastatic Appendiceal Adenocarcinoma.
Oncologist
; 28(12): e1303-e1305, 2023 Dec 11.
Article
in English
| MEDLINE | ID: mdl-37738316
16.
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 383(24): 2345-2357, 2020 12 10.
Article
in English
| MEDLINE | ID: mdl-32955174
17.
Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study.
Breast Cancer Res Treat
; 199(1): 67-79, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36877215
18.
Impact of Relative Dose Intensity of Docetaxel, Cisplatin, and 5-Fluorouracil Neoadjuvant Chemotherapy on Survival of Esophageal Squamous Cell Cancer Patients.
Oncology
; 101(3): 203-212, 2023.
Article
in English
| MEDLINE | ID: mdl-36599320
19.
Targeting prostate cancer with docetaxel-loaded peptide 563-conjugated PEtOx-co-PEI30%-b-PCL polymeric micelle nanocarriers.
Amino Acids
; 55(8): 1023-1037, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37318626
20.
Enhanced chemotherapeutic efficacy of docetaxel in human lung cancer cell line via GLUT1 inhibitor.
J Biochem Mol Toxicol
; 37(6): e23348, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-36999407